FebriDx® Method Comparison Study Protocol
Public ClinicalTrials.gov record NCT06746259. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CLP-0019- FebriDx® Method Comparison Study Protocol
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this observational study is to learn about the performance and ease of use of FebriDx when operated by persons without laboratory experience or training in patients with acute respiratory symptoms. The main question it aims to answer is: • Is FebriDx accurate at differentiating bacterial from non-bacterial respiratory infections when used by untrained operators? Trained and untrained participants will run the FebriDx test on patients with respiratory symptoms to evaluate comparability.
Study identification
- NCT ID
- NCT06746259
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 800 participants
Conditions and interventions
Conditions
Interventions
- Rapid point of care test to detect host immune response in ARI Diagnostic Test
Diagnostic Test
Eligibility (public fields only)
- Age range
- 12 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 20, 2024 (Actual)
- Primary completion
- Aug 15, 2025 (Actual)
- Completion
- Aug 31, 2025 (Actual)
- Last update posted
- Sep 9, 2025
2024 – 2025
United States locations
- U.S. sites
- 8
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ascada Health | Fullerton | California | 92835 | — |
| Exer Urgent Care | Pasadena | California | 91105 | — |
| L&C | Miami | Florida | 33144 | — |
| Trujillo Medical Center | Miramar | Florida | 33027 | — |
| Hillcrest Medical Research, LLC | Orange City | Florida | 32763 | — |
| Hometown Urgent Care and Research | Beavercreek | Ohio | 45430 | — |
| HMG Clinical Research/Herrera Medical Group | Bedford | Texas | 76021 | — |
| Ascada Health | Katy | Texas | 77494 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06746259, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 9, 2025 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06746259 live on ClinicalTrials.gov.